Lecanamab: Controversial Alzheimer's drug approved by Australian drugs regulator after two rejections. Nogrady B. BMJ 2025;390:r2056.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nogrady B. Lecanamab: Controversial Alzheimer's drug approved by Australian drugs regulator after two rejections. BMJ 2025;390:r2056.
PMID: 41027722